<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32019</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Molecular serological characteristics of weak D antigen types of the Rhesus system</article-title><trans-title-group xml:lang="ru"><trans-title>Молекулярно-серологические характеристики типов слабого антигена D системы резус</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golovkina</surname><given-names>L L</given-names></name><name xml:lang="ru"><surname>Головкина</surname><given-names>Л Л</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stremoukhova</surname><given-names>A G</given-names></name><name xml:lang="ru"><surname>Стремоухова</surname><given-names>А Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pushkina</surname><given-names>T D</given-names></name><name xml:lang="ru"><surname>Пушкина</surname><given-names>Т Д</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kalandarov</surname><given-names>R S</given-names></name><name xml:lang="ru"><surname>Каландаров</surname><given-names>Р С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Atroshchenko</surname><given-names>G V</given-names></name><name xml:lang="ru"><surname>Атрощенко</surname><given-names>Г В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vasilyeva</surname><given-names>M N</given-names></name><name xml:lang="ru"><surname>Васильева</surname><given-names>М Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Surin</surname><given-names>V L</given-names></name><name xml:lang="ru"><surname>Сурин</surname><given-names>В Л</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Salomashkina</surname><given-names>V V</given-names></name><name xml:lang="ru"><surname>Саломашкина</surname><given-names>В В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pshenichnikova</surname><given-names>O S</given-names></name><name xml:lang="ru"><surname>Пшеничникова</surname><given-names>О С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Miterev</surname><given-names>G Yu</given-names></name><name xml:lang="ru"><surname>Митерев</surname><given-names>Г Ю</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Parovichnikova</surname><given-names>E N</given-names></name><name xml:lang="ru"><surname>Паровичникова</surname><given-names>Е Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savchenko</surname><given-names>V G</given-names></name><name xml:lang="ru"><surname>Савченко</surname><given-names>В Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Гематологический научный центр Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2016</year></pub-date><volume>88</volume><issue>7</issue><issue-title xml:lang="en">VOL 88, NO7 ()</issue-title><issue-title xml:lang="ru">ТОМ 88, №7 (2016)</issue-title><fpage>78</fpage><lpage>83</lpage><history><date date-type="received" iso-8601-date="2020-04-10"><day>10</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/32019">https://ter-arkhiv.ru/0040-3660/article/view/32019</self-uri><abstract xml:lang="en"><p>Aim. To estimate the spread of weak D antigen types of the Rhesus system in the citizens of the Russian Federation and a possibility of serologically identifying these types. Subjects and methods. The red blood cells and DNA of people with weakened expression of D antigen were investigated using erythrocyte agglutination reaction in salt medium (2 methods); agglutination reaction in the gel columns containing IgM + IgG anti-D antibodies, indirect antiglobulin test with IgG anti-D antibodies (2 methods); polymerase chain reaction to establish the type of weak D. Results. A rhesus phenotype was determined in 5100 people in 2014-2015. The weakened agglutinable properties of red blood cells were detected in 102 (2%) examinees. 63 examinees underwent genotyping to identify the variants of the weak D antigen, which identified 6 weak D types. There were the most common weak D types 3 (n=31 (49.2%)) and weak D type 1 (n=18 (28.6%)), including weak D type 1.1 in one (1.6%) case. The other 4 weak D antigen types were as follows: weak D type 2 (14.3% (n=9)), weak D type 15 (4.8% (n=3)), weak D type 4.2 (DAR) (1.6% (n=1)) and weak D type 6 (1.6% (n=1)). The antiglobulin test in the gel column containing antiglobulin serum was the most sensitive serological assay to identify the weak D antigen. Only a molecular test could establish weak D type 15 in 2 samples of red blood cells with Ccdee and ccdEe phenotypes. Conclusion. The weak D antigen could be serologically identified in 96.8% of cases. When testing for weak D, particular attention should be given to people with the D-negative phenotype who had the C or E antigens. Our investigations conducted for the first time in Russia will be able to improve the immunological safety of red blood cell-containing medium transfusions for patients.</p></abstract><trans-abstract xml:lang="ru"><p>Резюме Цель исследования. Оценка распространенности типов слабого антигена D (weak D) системы резус у россиян и возможности выявления этих типов серологическими методами. Материалы и методы. Исследовали эритроциты и ДНК людей с ослабленной экспрессией антигена D с помощью реакции агглютинации эритроцитов в солевой среде (2 метода); реакции агглютинации в гелевых колонках с IgM+IgG анти-D-антителами, непрямого антиглобулинового теста с IgG анти-D-антителами (2 метода); полимеразной цепной реакции для установления типа weak D. Результаты. В 2014-2015 гг. резус-фенотип определен у 5100 человек. Ослабление агглютинабельных свойств эритроцитов выявлено у 102 (2%) обследованных. Генотипирование для идентификации вариантов антигена weak D проведено у 63 обследованных, выявлено 6 типов weak D. Наиболее частыми оказались типы weak D type 3 (n=31; или 49,2%) и weak D type 1 (n=18; или 28,6%), в том числе в одном случае weak D type 1.1 (1,6%). Остальные 4 типа антигена weak D имели следующие частоты: weak D type 2 - 14,3% (n=9), weak D type 15 - 4,8% (n=3), weak D type 4.2 (DAR) (n=1) и weak D type 6 (n=1) - по 1,6% каждый. Наиболее чувствительным серологическим методом идентификации антигена weak D был антиглобулиновый тест в гелевых колонках, содержащих антиглобулиновую сыворотку. В 2 образцах эритроцитов с фенотипами Ccdee и ccdEe наличие weak D type 15 установлено только молекулярным методом. Заключение. Серологическими методами слабый антиген D выявлен в 96,8% случаев. Особое внимание при проверке на наличие weak D следует уделять людям с D-отрицательным фенотипом, имеющим антигены С или Е. Наши исследования, проведенные впервые в России, позволят улучшить иммунологическое обеспечение безопасности трансфузий пациентам сред, содержащих эритроциты.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Rhesus system</kwd><kwd>weak D antigen types</kwd><kwd>phenotype</kwd><kwd>antigen expression</kwd><kwd>genotype</kwd><kwd>prevention of alloimmunization</kwd><kwd>red blood cell transfusions</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>система резус</kwd><kwd>типы слабого антигена D</kwd><kwd>фенотип</kwd><kwd>экспрессия антигена</kwd><kwd>генотип</kwd><kwd>профилактика аллоиммунизации</kwd><kwd>трансфузии эритроцитов</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cherif-Zahar B, Mattei MG, Le van Kim C, Bailly P, Carton JP, Collin Y. Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Human Genet. 1991;6:398-400. doi:10.1007/BF00201843</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Okuda H, Suganuma H, Kamesaki T, Kumada M, Tsudo N, Omi T, Iwamoto S, Kajii E. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE through complete sequencing. Biochem Biophys Res Communicat. 2000;274:670-683. doi:10.1006/bbrc.2000.3206</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood. 2000;95:3662-3668. doi:10.1016/S0887-7963(01)80058-4</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Scott M. Rh serology - Coordinators report. Transfusion Clin. Biol. 1996; 3: 333-337. doi:10.1016/s1246-7820(96)80040-1</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Scott M., Section L.A. Rh serology. Coordinators report. Transfusion Clinique Biologique. 2002;9:23-29. doi:10.1016/s1246-7820(01)00211-7</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Liu W, Avent ND, Jones JW, Scott ML, Voak D. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood. 1999;94(12):3986-3996.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Daniels G. Variants of RhD - current testing and clinical consequences. Br J Haematol. 2013;161:461-470. doi:10.1111/bjh.12275</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Shao CP, Maas JH, Su YQ, Kohler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002;83(2):156-161. doi:10.1046/j.1423-0410.2002.00192.x</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Stratton F. A new Rh allelomorph. Nature. 1946;158:25-26. doi:10.1038/158025c0</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Agre PC, Davies DM, Issitt PD, Lamy BM, Schmidt PJ, Treacy M, Vengelen-Tyler V. A proposal to standardize terminology for weak D antigen. Transfusion. 1992;32:86-87. doi:10.1046/j.1537-2995.1992.32192116441.x</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rhesus base website, http://www.uni-ulm.de/fwagner/RH/RB.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999;93:385-393.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Avent ND, Madgett TE, Lee ZE, Head DJ, Maddocks DG, Skinner LH. Molecular biology of Rh protein and relevance to molecular medicine. Expert Rev Mol Med. 2006; 8:1-20. doi:10.1017/S1462399406010969</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Conroy MJ, Bullough PA, Merrick M, Avent ND. Modeling the human rhesus proteins: implications for structure and function. Br J Hematol. 2005;131:543-551. doi:10.1111/j.1365-2141.2005.05786.x</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apheresis Scie. 2011;44:81-91. doi:10.1016/j.transci.2010.12.013</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wagner FF, Frohmajer A, Ladewig B, Eicher NI, Lonicer CB, Muller TH, Siegel MH, Flegel WA. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699-2708. doi:10.1016/S0887-7963(01)80057-2</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Dogic V, Bingulac-Popovic J, Babic I, Hundric-Haspl Z, Jurakovic-Loncar N, Mratinovic-Mikulandra J, Vuk T, Balija M, Jukic I. Distribution of weak D types in Croatian population. Transfus Med. 2011;21:278-279. doi:10.1111/j.1365-3148.2011.01071.x</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rodrigues MJ, Rodrigues F, Tilley L, Poole I, Chabert T, Sousa G. Several new examples of weak D type 38 in the Portuguese population. Transfusion. 2006;46(suppl.):141A-142A (abstract). doi:10.1111/j.1537-995.2006.01023_1.x</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>St-Louis M, Richard M, Cote M, Ethier C, Long A. Weak D type 42 cases found in individuals of European descent. Immunohematology. 2011;27:20-24.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Jonson ST, Katz L, Queenan JT, Vassallo RR, Simon CD. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion. 2015;55:680-689. doi:10.1111/trf.12941</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Levitt J, ed. Standards for blood banks and transfusion service. 29th ed. Bethesda (MD): American Association of Blood Banks; 2014.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Головкина Л.Л., Стремоухова А.Г., Пушкина Т.Д., Оловникова Н.И. Случай выявления антигена системы Резус D weak 15-го типа. Гематология и трансфузиология. 2014;59(4):23-24.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Пискунова Т.М. Изучение некоторых изоантигенов крови человека и создание кадров доноров и резерва замороженной крови редких групп: Автореф. дис. ... канд. мед. наук. М.; 1970.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Пискунова Т.М. Редкий фактор крови Du. Проблемы гематологии. 1973;5:3-9.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Оловникова Н.И., Митерев Г.Ю. Современная стратегия определения резус-принадлежности крови: проблема Du фенотипа в трансфузиологической и акушерской практике. Справочник заведующего КДЛ. 2010;4:5-16.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Haspel RL, Westhoff CM. How do I manage Rh typing in obstetric patients? Transfusion. 2015;55:470-474. doi:10.1111/trf.12995</mixed-citation></ref></ref-list></back></article>
